Drug Comparison

Empagliflozin (Jardiance) vs. Dapagliflozin (Farxiga): SGLT2 Inhibitors Compared

Empagliflozin (Jardiance) and Dapagliflozin (Farxiga) are both SGLT2 inhibitor medications that help lower blood sugar by increasing sugar removal through urine. They are often compared because they treat similar conditions, including type 2 diabetes, heart failure, and chronic kidney disease, offering significant benefits beyond just blood sugar control.

Side-by-Side Comparison

CategoryEmpagliflozinDapagliflozin
Drug ClassSGLT2 InhibitorSGLT2 Inhibitor
Primary MechanismBlocks SGLT2 to prevent glucose reabsorption in kidneys, increasing glucose excretion in urine.Blocks SGLT2 to prevent glucose reabsorption in kidneys, increasing glucose excretion in urine.
Key IndicationsType 2 diabetes, reduce risk of cardiovascular death and hospitalization for heart failure, reduce risk of kidney disease progression.Type 2 diabetes, reduce risk of cardiovascular death, hospitalization for heart failure, and kidney disease progression.
Cardiovascular Benefit FocusSpecifically indicated to reduce cardiovascular death and hospitalization for heart failure.Indicated to reduce cardiovascular death and hospitalization for heart failure.
Kidney Benefit FocusIndicated to reduce risk of sustained decline in eGFR, end-stage kidney disease, cardiovascular death, and hospitalization.Indicated to reduce risk of sustained eGFR decline, end-stage kidney disease, cardiovascular death, and hospitalization for heart failure.
Major WarningRisk of diabetic ketoacidosis, especially in type 1 diabetes.Risk of diabetic ketoacidosis, especially in type 1 diabetes.
When to ChooseA doctor might prefer Empagliflozin (Jardiance) if the patient has heart failure, as it has a strong indication for reducing cardiovascular death and hospitalization for heart failure. Its kidney protection benefits are also robust, making it a good choice for patients with chronic kidney disease.A doctor might choose Dapagliflozin (Farxiga) for patients with type 2 diabetes, heart failure, or chronic kidney disease, given its broad indications across these conditions. It offers similar benefits in reducing the risk of cardiovascular events and kidney disease progression.
Side EffectsBoth Empagliflozin and Dapagliflozin share similar side effect profiles due to their common mechanism of action. Common side effects include urinary tract infections, yeast infections, and increased urination. Both also carry a warning for diabetic ketoacidosis, especially in patients with type 1 diabetes, and can cause dehydration.
CostNeither Empagliflozin (Jardiance) nor Dapagliflozin (Farxiga) are currently available as generics in the United States. As brand-name medications, their costs are generally high and can vary significantly based on insurance coverage and pharmacy.

Bottom Line

Empagliflozin (Jardiance) and Dapagliflozin (Farxiga) are very similar SGLT2 inhibitors offering significant benefits for type 2 diabetes, heart failure, and chronic kidney disease. The choice between them often comes down to specific patient characteristics, physician preference, and insurance coverage, as their efficacy and safety profiles are largely comparable across their approved indications.

Empagliflozin Overview

Empagliflozin (Jardiance) is a medication that helps your kidneys remove extra sugar from your body through urine. It is prescribed to treat type 2 diabetes by lowering blood sugar, and also helps reduce the risk of heart-related problems and hospitalizations in adults with heart failure or chronic kidney disease.

Full Empagliflozin guide →

Dapagliflozin Overview

Dapagliflozin (brand name: DAPAGLIFLOZIN) is a medication that helps your kidneys remove excess sugar from your body. It is used to treat type 2 diabetes, heart failure, and chronic kidney disease by improving blood sugar control and protecting your heart and kidneys.

Full Dapagliflozin guide →

Compare prices for Empagliflozin and Dapagliflozin

Check real-time pharmacy prices before you fill — free, no account needed.

Medical Disclaimer

The information on RxGuide is intended for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician, pharmacist, or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.